SciCombinator

Discover the most talked about and latest scientific content & concepts.

H Rinta-Kokko, AA Palmu, K Auranen, JP Nuorti, M Toropainen, L Siira, MJ Virtanen, H Nohynek and J Jokinen
Abstract
The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Programme (NVP) in September 2010. The impact of PCV10 vaccination against invasive pneumococcal disease (IPD) in vaccine-eligible children has been high. We evaluated the long-term impact of PCV10 vaccination against IPD in vaccine-eligible and older, unvaccinated children six years after PCV10 introduction with a special focus on cross-protection against PCV10-related serotypes (serotypes in the same serogroups as the PCV10 types).
Tweets*
2
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
1
Concepts
Vaccination schedule, Vaccine, Microbiology, Pneumococcal vaccine, Pneumococcal polysaccharide vaccine, Streptococcus pneumoniae, Pneumonia, Pneumococcal conjugate vaccine
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com